Filtered By:
Management: Budgets
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 414 results found since Jan 2013.
A Thoughtful Discussion on Drug Pricing and Innovation
This post first appeared October 5 on the Prognosis Blog.
There has been a lot of talk of late about the price of prescription drugs. Most of it, unfortunately, has come in the form of 30-second sound bites, largely driven by one hedge fund investor’s decision to significantly raise the price of a single product.
Determining the correct price for an innovative, life-changing product to achieve both consumer accessibility as well as a return on investment, which is vital to fund future research and development, is a complex topic that warrants a thoughtful discussion, not glib attack lines.
Credit, then, goes to the Was...
Source: Disruptive Women in Health Care - October 14, 2015 Category: Consumer Health News Authors: dw at disruptivewomen.net Tags: Consumer Health Care Cost Policy Source Type: blogs
Panel Discussion: How Can Life Extension Become as Popular as the War on Cancer?
Given the BioViva press release I pointed out earlier today, you may be interested in listening to a Longevity Day roundtable held yesterday, since Elizabeth Parrish of BioViva was participating, as well as Keith Comito of the Life Extension Advocacy Foundation, and a few other names you might recognize. From my perspective it is great to see so much going on that I only find out about after the fact: one of the signs of a healthy and growing community is that people are off doing things and I have no idea, since there is too much to keep track of in any reasonable amount of time.
What can be done to raise public suppor...
Source: Fight Aging! - October 2, 2015 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs
Health Affairs’ September Issue: Growing Burden Of Noncommunicable Diseases
The September issue of Health Affairs focuses on the growing burden of noncommunicable diseases. Increased wealth worldwide has reduced the frequency of some infectious diseases, while chronic diseases—heart disease, respiratory ailments, cancer, diabetes, mental illness, and others—are more widespread. The September issue was supported by Eli Lilly and Company.
Tracking Global Mortality Over 30 Years: A Mix of Increases And Decreases
Mohammed Ali at Emory University’s Rollins School of Public Health and coauthors examined data on deaths as a result of ischemic heart disease, stroke, diabetes, respiratory d...
Source: Health Affairs Blog - September 8, 2015 Category: Health Management Authors: Tracy Gnadinger Tags: Costs and Spending Elsewhere@ Health Affairs Equity and Disparities Featured Global Health Medicaid and CHIP Population Health Public Health Quality ACA DataWatch Global Mortality HSAs NCDs noncommunicable diseases WHO Source Type: blogs
Quantifying Planned Parenthood’s Critical Role In Meeting The Need For Publicly Supported Contraceptive Care
Over the past few months, legislative attempts to defund Planned Parenthood have flared at both the federal and state levels; these moves are clearly an attempt to shutter Planned Parenthood health centers, potentially depriving women of the contraceptive services and counseling, sexually transmitted infection (STI) testing and treatment, and breast and cervical cancer screening that they provide.
Although proponents of closing Planned Parenthood argue that other providers would be easily able to fill the hole torn in the safety net, credible evidence suggests this is unlikely. In some areas, Planned Parenthood is the sole...
Source: Health Affairs Blog - September 8, 2015 Category: Health Management Authors: Jennifer Frost and Kinsey Hasstedt Tags: Costs and Spending Equity and Disparities Featured Long-term Services and Supports Population Health Public Health contraceptive coverage low-income women Planned Parenthood safety-net providers Women's Health Source Type: blogs
China’s Enduring Hatred of Japan Could Spark Renewed Conflict Involving U.S.
BEIJING—There are many obscure tourist sites in Beijing. One missed by many foreigners is the Chinese People’s Anti-Japanese War Memorial Hall.
The museum illustrates why China, America’s most fearsome potential competitor, and Japan, Washington’s most important Asian ally, often are at odds. The two are a conflict waiting to happen, which could draw the U.S. into war with a nuclear power.
Chinese President Xi Jinping presided over last week’s World War II victory parade in Beijing. However, the conflict with Japan continues in many people’s minds.
Following Washington’s lead, Tokyo did not recognize the PRC ...
Source: Cato-at-liberty - September 8, 2015 Category: American Health Authors: Doug Bandow Source Type: blogs
Planned Parenthood, Community Health Centers, And Women’s Health: Getting The Facts Right
The current Planned Parenthood fight, one of the most disturbing battles over women’s health in recent years, has been riddled with inaccuracies. A particularly damaging one is the assertion that the nation’s community health centers could pick up the slack if Planned Parenthood is defunded.
I have worked with community health centers for nearly 40 years, and no one believes more strongly than I do in their ability to transform the primary health care landscape in medically underserved low-income communities. But a claim that community health centers readily can absorb the loss of Planned Parenthood clinics amounts to ...
Source: Health Affairs Blog - September 2, 2015 Category: Health Management Authors: Sara Rosenbaum Tags: Costs and Spending Equity and Disparities Featured Health Professionals Long-term Services and Supports Organization and Delivery Population Health Public Health Quality Community Health Centers family planning funding Health Polic Source Type: blogs
PCORI is Starting to Click. Give It a Chance.
By STEVE FINDLAY
Earlier this month the Center for Public Integrity (CPI) published a sharp-edged piece on PCORI—the Patient-Centered Outcomes Research Institute.
The piece raised some salient issues and it’s timely to take stock of PCORI at the half way point of its authorized funding. (Unless renewed, PCORI sunsets in 2019.)
The Affordable Care Act created PCORI as an independent nonprofit (non-government) entity. But PCORI’s funding and structure makes it more or less quasi-government. It gets its money from the Medicare trust fund, treasury general funds, and a tax on private insurers and self-funded i...
Source: The Health Care Blog - August 26, 2015 Category: Consumer Health News Authors: John Irvine Tags: THCB Source Type: blogs
Title X: The Lynchpin Of Publicly Funded Family Planning In The United States
The Title X national family planning program was created 45 years ago with broad bipartisan support. Today, Congress has Title X—still the only federal grant program dedicated entirely to family planning and related preventive health care—in its sights for severe funding cuts or even elimination.
The U.S. House of Representatives has proposed ending the program for the fifth year in a row, and the U.S. Senate is recommending a sizable reduction to Title X’s budget. In addition, while legislation aimed at defunding Planned Parenthood and its affiliates, whose health centers serve one-third of Title X clients n...
Source: Health Affairs Blog - August 10, 2015 Category: Health Management Authors: Kinsey Hasstedt Tags: Costs and Spending Equity and Disparities Featured Long-term Services and Supports Population Health Public Health Quality ACA family planning Planned Parenthood Title X Women's Health Source Type: blogs
“Bad Guy” Big Pharma: An Easy Target?
<p style="font-size: 11.1999998092651px; line-height: 19.0400009155273px;"><span style="font-size: 11.1999998092651px; line-height: 19.0400009155273px;">Do Americans always need an entire industry to hate or complain about? Big tobacco, big banks, big insurers, big brokerage houses, big oil and energy companies, big automakers, big for-profit hospital companies, big pharma, have all been easy targets in the past. More often than not because of big profits, abuses and excesses, and safety concerns. On July 23, 2015, The New York Times fired another salvo at big pharma when it published Andrew...
Source: blog.bioethics.net - August 6, 2015 Category: Medical Ethics Authors: Hayley Dittus-Doria Tags: Health Care Pharmaceuticals cost drug safety syndicated Source Type: blogs
At 50, Medicare and Medicaid Face the Challenge of a New Generation of Super-Expensive Drugs
By STEVEN FINDLAY
Happy birthday Medicare and Medicaid! Fifty years old today. Middle age. Congratulations. You’ve survived a lot—and 76 million baby boomers and 60 million low-income Americans are mighty glad you’re still around, covering one in three Americans, with solvency until 2030 at last accounting.
Unfortunately, the challenges are not going to let up. In fact, they’re likely to get worse. Those challenges are discussed at length in several places that celebrate this milestone—most notably here, here, here, in the current issue of the Journal of the American Medical Association (s...
Source: The Health Care Blog - July 30, 2015 Category: Consumer Health News Authors: suchandan roy Tags: THCB Steven Findlay Source Type: blogs
Spending Growth Trends: Keeping An Eye On Spending Per Person
New health spending data for 2014 and spending projections over the next decade from the Centers for Medicare and Medicaid Services (CMS) Office of the Actuary were just published in Health Affairs. They show that total growth in health spending picked up in 2014; this was expected given the significant expansion of insurance coverage and the release of expensive new drugs for hepatitis C.¹
But all of the evidence points to continued modest growth in per capita/enrollee spending. This low growth in per enrollee costs is a strong signal that we may be in an era where the “new normal” is more restrained growth in the us...
Source: Health Affairs Blog - July 28, 2015 Category: Health Management Authors: Melinda Buntin Tags: Costs and Spending Drugs and Medical Technology Featured Health Professionals Hospitals Insurance and Coverage Medicaid and CHIP Medicare Altarum symposium CMS Office of the Actuary Consumers Health IT Melinda Buntin transparency Source Type: blogs
What Company Will You Keep? Strategy In Health Care’s New Era
By JOE FLOWER
How do you plan? Obviously, you have to. Obviously, you can’t.
For your organization, and for you as a health care leader, the rapid and, at times, chaotic changes in the payment systems, the purchasers’ strategies, your population base, new technological possibilities, and the competitive landscape mean that you must plan for the future and act vigorously to make that future happen — or you fail. At the same time, those very same factors render traditional planning methods irrelevant, impossible, even deadly.
The movie line that comes to mind is, “Forget it, Jake. It’s Chinatown....
Source: The Health Care Blog - July 15, 2015 Category: Consumer Health News Authors: John Irvine Tags: THCB Change Management Complex Adaptive System Source Type: blogs
Looking At The Future Of Alzheimer’s Disease Policy
It is time to engage public health in aggressive efforts to address Alzheimer’s disease and other dementias (AD/D) without delay.
As I noted in Health Affairs in April 2014, numerous U.S. states are already taking some action. Since then an additional 12 states, for a total of 40 states, have developed state plans to address AD/D. Most are already published, with a few in development or being scheduled for updating.
Public policy statements at all levels call for coordination of resources, better communication, awareness, and essential linkages. Now to achieve the outcomes envisioned in these plans and policies, further ...
Source: Health Affairs Blog - July 14, 2015 Category: Health Management Authors: David Hoffman Tags: Costs and Spending Health Policy Lab Long-term Services and Supports Population Health Public Health Aging Alzheimer's Chronic Condition David Hoffman Dementia Long-Term Care New York Source Type: blogs
After King v. Burwell, A New Opportunity To Build On Early Success
This article is part of a series of blog posts by leaders in health and health care who participated in Spotlight Health from June 25-28, the opening segment of the Aspen Ideas Festival. This year’s theme was Smart Solutions to the World’s Toughest Challenges. Stayed tuned for more.
On June 25, Chief Justice Roberts quoted Marbury v. Madison in writing for the six-judge majority that decided King v. Burwell, a challenge to the tax subsidies for millions of Americans’ health insurance payments. Roberts wrote “in a democracy, the power to make law rests with those chosen by the people. Our [the Supreme Court’s] ...
Source: Health Affairs Blog - July 2, 2015 Category: Health Management Authors: Kathleen Sebelius Tags: Costs and Spending Equity and Disparities Featured Following the ACA Insurance and Coverage Medicaid and CHIP Payment Policy Population Health Public Health Chevron King v. Burwell Medicaid expansion Spotlight Health Source Type: blogs
What’s Next For The Affordable Care Act? Life After King v. Burwell
In the not-too-distant future, the U.S. Supreme Court’s 6-3 decision in King v. Burwell will be viewed as a significant turning point for the Affordable Care Act (ACA). Simply stated, the ACA is not only the law of the land — it will remain the law of the land. And I believe that the Court’s decision foreshadows an end to the contentious and partisan fights about the ACA’s existence; slowly but surely, a search for common purpose on health care will begin among conservatives and progressives, Republicans and Democrats.
To be sure, this change will not occur overnight. As their reactions to the Court’s decisio...
Source: Health Affairs Blog - June 29, 2015 Category: Health Management Authors: Ron Pollack Tags: Costs and Spending Equity and Disparities Featured Following the ACA Insurance and Coverage Affordable Care Act family glitch King v. Burwell Medicaid expansion out-of-pocket health care costs Source Type: blogs
